Trademark: 88664801
Word
GLYFEX
Status
Dead
Status Code
606
Status Date
Monday, November 29, 2021
Serial Number
88664801
Mark Type
4000
Filing Date
Wednesday, October 23, 2019
Published for Opposition
Tuesday, March 3, 2020
Abandoned Date
Monday, November 29, 2021

Trademark Owner History
Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabetes, diabetic complications, and hormonal diseases and disorders

Trademark Events
Nov 29, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 29, 2021
Abandonment - No Use Statement Filed
Oct 28, 2021
Teas Change Of Correspondence Received
Oct 28, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 28, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 28, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 14, 2021
Extension 2 Granted
Apr 14, 2021
Extension 2 Filed
Apr 14, 2021
Teas Extension Received
Oct 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2020
Extension 1 Granted
Oct 26, 2020
Extension 1 Filed
Oct 26, 2020
Teas Extension Received
Apr 28, 2020
Noa E-Mailed - Sou Required From Applicant
Mar 3, 2020
Official Gazette Publication Confirmation E-Mailed
Mar 3, 2020
Published For Opposition
Feb 12, 2020
Notification Of Notice Of Publication E-Mailed
Jan 24, 2020
Approved For Pub - Principal Register
Jan 23, 2020
Assigned To Examiner
Oct 29, 2019
New Application Office Supplied Data Entered In Tram
Oct 26, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24